Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+17.95%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$10.2B
AUM Growth
+$1.96B
(+24%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
43.19%
Holding
1,081
New
132
Increased
418
Reduced
456
Closed
74
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$295M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$118M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$97.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$55.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$27.6M |
Top Sells
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$107M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$32.9M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$17.7M |
| 4 |
Lockheed Martin
LMT
|
+$13.5M |
| 5 |
Apple
AAPL
|
+$10.9M |
Sector Composition
| 1 | Technology | 26.66% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 3.24% |
| 4 | Energy | 3.1% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
FuelCell Energy
FCEL
$118M
| $846K | 0.01% |
+2,524
| New | +$846K |
|
552
FibroGen
FGEN
$46.1M
| $843K | 0.01% |
909
-973
| -52% | -$902K |
|
|
NNDM
553
Nano Dimension
NNDM
$326M
| $842K | 0.01% |
+92,521
| New | +$842K |
|
554
Sempra
SRE
$52.5B
| $838K | 0.01% |
13,154
-36,826
| -74% | -$2.35M |
|
555
BioCryst Pharmaceuticals
BCRX
$1.69B
| $837K | 0.01% |
112,351
-413,951
| -79% | -$3.08M |
|
556
Expedia Group
EXPE
$26.9B
| $836K | 0.01% |
6,313
-31,133
| -83% | -$4.12M |
|
557
HCA Healthcare
HCA
$97.1B
| $834K | 0.01% |
5,070
-483
| -9% | -$79.5K |
|
558
Novavax
NVAX
$1.31B
| $832K | 0.01% |
7,465
-13,323
| -64% | -$1.48M |
|
|
FIT
559
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $831K | 0.01% |
122,143
+95,789
| +363% | +$652K |
|
560
Mersana Therapeutics
MRSN
$35.6M
| $827K | 0.01% |
1,243
-1,855
| -60% | -$1.23M |
|
561
Opko Health
OPK
$1.13B
| $827K | 0.01% |
209,485
-454,112
| -68% | -$1.79M |
|
562
Cytokinetics
CYTK
$6.11B
| $825K | 0.01% |
39,725
-31,392
| -44% | -$652K |
|
563
Akebia Therapeutics
AKBA
$795M
| $823K | 0.01% |
294,029
-220,207
| -43% | -$616K |
|
564
Ambarella
AMBA
$3.59B
| $812K | 0.01% |
+8,839
| New | +$812K |
|
565
Kirby Corp
KEX
$4.88B
| $812K | 0.01% |
15,673
+5,584
| +55% | +$289K |
|
566
AvalonBay Communities
AVB
$27.7B
| $811K | 0.01% |
5,053
+212
| +4% | +$34K |
|
|
CTLT
567
DELISTED
CATALENT, INC.
CTLT
| $811K | 0.01% |
7,793
+251
| +3% | +$26.1K |
|
|
SRNE
568
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $808K | 0.01% |
118,452
-195,498
| -62% | -$1.33M |
|
569
Alexandria Real Estate Equities
ARE
$14.4B
| $807K | 0.01% |
4,530
+189
| +4% | +$33.7K |
|
|
ADAP
570
Adaptimmune Therapeutics
ADAP
$12.5M
| $803K | 0.01% |
+149,060
| New | +$803K |
|
571
ImmunityBio
IBRX
$2.45B
| $801K | 0.01% |
+60,089
| New | +$801K |
|
572
Varonis Systems
VRNS
$6.39B
| $796K | 0.01% |
+14,601
| New | +$796K |
|
573
Equity Residential
EQR
$25.4B
| $792K | 0.01% |
13,364
-27,059
| -67% | -$1.6M |
|
574
MongoDB
MDB
$26.9B
| $791K | 0.01% |
+2,203
| New | +$791K |
|
575
Immunovant
IMVT
$2.86B
| $784K | 0.01% |
16,968
-4,567
| -21% | -$211K |
|